Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...
Integrated Biosciences has a new Chief Scientific Officer (CSO), naming Daniel J. Anderson, PhD, to the post. Anderson joins ...
Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced the expansion of co-founder Dr. Marinna Madrid's role to Chief Product and ...
Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...
Microsoft programs appear to be suffering an outage.
Integrated Biosciences, a biotechnology company combining synthetic biology, chemistry, and AI to discover small-molecule therapeutics for age-related diseases, today announced the appointment of ...
Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...
Information pervades the universe, yet means nothing. Meaning emerged when matter organized into systems that could ...
Explore how real estate tokenization works through smart contract architecture, enabling secure, transparent property ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results